Search Within

Issam S. Hamadeh

Formats
  1. Meeting Abstract (17)
  2. Journal Article (5)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Clinical Pharmacy Specialists (25)
  2. Hematologic Malignancies, Division of (23)
  3. Center for Hematologic Malignancies (22)
  4. Department of Medicine (22)
  5. Myeloma (22)
  6. Bone Marrow Transplant (21)

More Groups

People
  1. Carlyn Rose Tan (22)
  2. Sham Mailankody (22)
  3. Alexander Lesokhin (21)
  4. Hani Hassoun (21)
  5. Heather Landau (21)
  6. Kylee Maclachlan (21)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (5)
  4. 2022 (2)
Publications
  1. Blood (10)
  2. Clinical Lymphoma, Myeloma and Leukemia (7)
  3. Blood Advances (5)
  4. Annals of Hematology (1)
  5. Cancer Management and Research (1)
  6. Frontiers in Oncology (1)
Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (7)
  3. Dove Medical Press Ltd (1)
  4. Frontiers Media S.A. (1)
  5. Springer (1)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Rajeeve, S.; Jurgens, E.; Nishimura, N.; Farzana, T.; Firestone, R.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Tan, C.; Shekarkhand, T.; Firestone, R.; Jurgens, E.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; Rajeeve, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cells: A review on current status and future directions for relapsed/refractory multiple myeloma
    Review

    Hamadeh, I. S.; Friend, R.; Mailankody, S.; Atrash, S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice
    Journal Article

    Chojecki, A.; Boselli, D.; Dortilus, A.; Hamadeh, I.; Begley, S.; Chen, T.; Bose, R.; Podoltsev, N.; Zeidan, A. M.; Balmaceda, N. B.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
    Journal Article

    Howard, A. J.; Concepcion, I.; Wang, A. X.; Hamadeh, I. S.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Korde, N.; Lesokhin, A. M.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Journal Article

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M. L.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naìˆve multiple myeloma
    Journal Article

    Firestone, R. S.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Qin, W. G.; Patel, D.; Tan, C. R.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save